Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-21-003787

Options or other derivatives

  • Chief Operating Officer acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Patel Kinnari · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-04 Grant or award : show line 1 in the form Stock Option (Right to Buy) +120,000 $62.32 2031-02-03 120,000 120,000 D
Loading xslF345X03/form4.xml…